Functional Analysis of 3 ′ UTR Variants at the LDLR and PCSK9 Genes in Patients with Familial Hypercholesterolemia
Human Mutation · 2024
DOI: 10.1155/2024/9964734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, 2024. Verfasst von Javier Sanguino Otero und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics of Metabolic Diseases, Hospital Universitario La Paz, Madrid, Spain. Hauptthemen laut MEDLINE: Proprotein Convertase 9, 3' Untranslated Regions, Hyperlipoproteinemia Type II, Receptors, LDL. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Union.
Abstract (Originalsprache)
Familial hypercholesterolemia (FH) is an autosomal dominant disease with an estimated prevalence of 1 in 200-250 individuals. Patients with FH are at increased risk of premature coronary artery disease. Early diagnosis and treatment are essential for improving clinical outcomes. In many cases, however, the genetic diagnosis is not confirmed. At present, routine genetic testing does not analyze the 3 ′ UTR regions of LDLR and PCSK9. However, 3 ′ UTR-single nucleotide variants could be of interest because they can modify the target sequence of miRNAs that regulate the expression of these genes. Our study fully characterizes the 3 ′ UTR regions of LDLR and PCSK9 in 409 patients with a suspected diagnosis of FH using next-generation sequencing. In 30 of the 409 patients, we found 21 variants with an allelic frequency of C showed a 41% decrease in luciferase expression, while PCSK9: c . ∗ 950 C > T showed a 41% increase in PCSK9 expression, results that could explain the hypercholesterolemia phenotype. In summary, the genetic analysis of the 3 ′ UTR regions of LDLR and PCSK9 could improve the genetic diagnosis of FH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics of Metabolic Diseases, Hospital Universitario La Paz, Madrid, Spain.
- Dyslipidemia of Genetic Origin and Metabolic Diseases Group, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
- Lipid and Vascular Unit, Hospital Carlos III, Madrid, Spain.
- Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain.
- Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.
- Department of Endocrinology and Nutrition, Hospital Ramón y Cajal, Madrid, Spain.
ORCID-Profile: Javier Sanguino Otero, Carmen Rodríguez-Jiménez, Jose Mostaza Prieto, Carlos Rodríguez-Antolín, Sonia Rodríguez-Nóvoa
Förderung
- Instituto de Salud Carlos III
- European Union
Zitieren
APA
Sanguino Otero, J., Rodríguez-Jiménez, C., Mostaza Prieto, J., Rodríguez-Antolín, C., Carazo Alvarez, A., Arrieta Blanco, F., & Rodríguez-Nóvoa, S. (2024). Functional Analysis of 3 ′ UTR Variants at the LDLR and PCSK9 Genes in Patients with Familial Hypercholesterolemia. Human Mutation. https://doi.org/10.1155/2024/9964734
Vancouver
Sanguino Otero J, Rodríguez-Jiménez C, Mostaza Prieto J, Rodríguez-Antolín C, Carazo Alvarez A, Arrieta Blanco F, et al. Functional Analysis of 3 ′ UTR Variants at the LDLR and PCSK9 Genes in Patients with Familial Hypercholesterolemia. Human Mutation. 2024. doi:10.1155/2024/9964734
BibTeX
@article{SanguinoOtero2024,
author = {Sanguino Otero, Javier and Rodríguez-Jiménez, Carmen and Mostaza Prieto, Jose and Rodríguez-Antolín, Carlos and Carazo Alvarez, Ana and Arrieta Blanco, Francisco and Rodríguez-Nóvoa, Sonia},
title = {Functional Analysis of 3 ′ UTR Variants at the LDLR and PCSK9 Genes in Patients with Familial Hypercholesterolemia},
journal = {Human Mutation},
year = {2024},
doi = {10.1155/2024/9964734}
}
EUVIMED